Format

Send to

Choose Destination
Pharmacotherapy. 2004 Dec;24(12 Pt 2):232S-8S.

Economics of antibiotic use policies.

Author information

1
State University of New York at Buffalo, and Clinical Outcomes and Pharmacoeconomics, CPL Associates LLC, Buffalo, New York 14226-1727, USA. paladino@cplassociates.com

Abstract

Today more than ever, hospitals must effectively manage the use of antibiotics to control costs and preserve their usefulness. To achieve this goal, antibiotic management must evolve from overly simplistic antibiotic cost containment to more complex, multidisciplinary, appropriate use programs that are founded on clinical outcomes-based pharmacoeconomic analyses. This article addresses common cost-containment activities as they relate to antibiotics and examines their consequences. Examples of successful antimicrobial stewardship and the role of pharmacoeconomic analyses also are provided. Cost-effectiveness studies of cefepime are presented to illustrate the utility of these analyses and provide information that can form the basis for decisions regarding placement of cefepime on hospital formularies.

PMID:
15585453
DOI:
10.1592/phco.24.18.232S.52234
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center